Search Results - "CLARKE, N.W."

Changing clinical study design using platform trial methodology: The STAMPEDE Trial 20 years on by Clarke, N.W.

Get full text

Understanding prostate cancer biology and treatment: The value of combining big data with basic and translational science by Clarke, N.W.

Get full text

The prognostic potential of the long non-coding RNA MALAT1 in prostate cancer by Hiew, K, Bokobza, S.M, Hart, C.A, Elliott, T, Smith, N.R, Brown, M, Clarke, N.W

Get full text

Comparative analysis of genomic alterations in lymph node, bone and visceral metastases in castration resistant prostate cancer by Ali, A., Haran, A.M., Hart, C.A., Brown, M.D., Clarke, N.W.

Get full text

The importance of lymph node location, burden and treatment outcome in M1 HSPC: analysis from the STAMPEDE trial arms A and C by Haran, Á.M., Ali, A., Hoyle, A., Hambrock, T., Amos, C., Jain, Y., James, N.D., Parmar, M.K.B., Sydes, M.R., Clarke, N.W.

Get full text

20LBA What is the current evidence for adding docetaxel or bisphosphonates to androgen deprivation therapy (ADT) in men with hormone sensitive prostate cancer? A systematic review and meta-analyses by Vale, C, Rydzewska, L.H, Tierney, J.F, Albiges, L, Clarke, N.W, Fisher, D.J, Fizazi, K, James, N.D, Mason, M.D, Parmar, M.K, Sweeney, C.J, Sydes, M.R, Tombal, B, Burdett, S

Get full text

2525 ASPIRE-PCa: Initial findings from a prospective, global observational study of men with late-stage prostate cancer by De Santis, M, Costello, A, Chang, Y.H, Clarke, N.W, Pickles, T, Bellm, L.A, Haas, G.P, Pompeo, A.C, Bazarbashi, S, Cooperberg, M.R

Get full text

Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al by James, N.D, Sydes, M.R, Clarke, N.W, Ritchie, A.W.S, Parmar, M.K.B

Get full text

19LBA Docetaxel (Doc) +/− zoledronic acid (ZA) for hormone-naive prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476) by James, N.D, Sydes, M.R, Mason, M.D, Clarke, N.W, Dearnaley, D.P, Spears, M.R, Millman, R, Parker, C.C, Ritchie, A.W.S, Russell, J.M, Staffurth, J, Jones, R.J, Cathomas, R, Robinson, A, Chowdhury, S, Tsang, D, Brock, S, Parikh, O, Graham, J.D, Parmar, M.K.B

Get full text

Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: Analysis of published case series data by Grogg, J.B., Fronzaroli, J.N., Bode, P., Oliveira, P., Lorch, A., Beyer, J., Eberli, D., Sangar, V., Hermanns, T., Clarke, N.W., Fankhauser, C.D.

Get full text

Impact of Node Status and Radiotherapy on Failure-Free Survival in Patients With Newly–Diagnosed Non-Metastatic Prostate Cancer: Data From >690 Patients in the Control Arm of the STAMPEDE Trial by James, N.D, Spears, M.R, Clarke, N.W, Sydes, M.R, Parker, C.C, Dearnaley, D.P, Russell, J.M, Ritchie, A.W.S, Thalmann, G, De Bono, J.S, Attard, G, Amos, C, Parmar, M.K, Mason, M.D

Get full text

Patient-reported urinary incontinence following radical prostatectomy for prostate cancer and its association with undergoing incontinence surgery: A national population-based study by Parry, M.G., Nossiter, J., Cowling, T.E., Sujenthiran, A., Berry, B., Aggarwal, A., Cathcart, P., Payne, H., Clarke, N.W., Skolarus, T., Van Der Meulen, J.

Get full text

Comparison of complications after transrectal and transperineal prostate biopsy: A national population-based study by Berry, B., Parry, M., Sujenthiran, A., Nossiter, J., Cowling, T.E., Aggarwal, A., Cathcart, P., Payne, H., Clarke, N.W., Van Der Meulen, J.

Get full text

Patient-reported outcomes after prostate only vs. prostate and pelvic lymph node radiation therapy by Parry, M.G., Nossiter, J., Cowling, T.E., Sujenthiran, A., Berry, B., Cathcart, p., Clarke, N.W., Payne, H., Van Der Meulen, J., Aggarwal, A.

Get full text

Patient-reported outcomes following a high-dose rate brachytherapy boost for prostate cancer by Parry, M.G., Nossiter, J., Cowling, T.E., Sujenthiran, A., Berry, B., Cathcart, P., Clarke, N.W., Payne, H., Van Der Meulen, J., Aggarwal, A.

Get full text

Trends and variations in risk stratified prostate cancer management: A cross-sectional study of the National Prostate Cancer Audit database using the Cambridge Prognostic Group criteria by Parry, M.G., Cowling, T.E., Sujenthiran, A., Nossiter, J., Berry, B., Cathcart, P., Aggarwal, A., Payne, H., Clarke, N.W., Van Der Meulen, J., Gnanapragasam, V.J.

Get full text

11 - Changing clinical study design using platform trial methodology: The STAMPEDE Trial 20 years on by Clarke, N.W.

Get full text

14 - Understanding prostate cancer biology and treatment: The value of combining big data with basic and translational science by Clarke, N.W.

Get full text

Celecoxib Plus Hormone Therapy Vs Hormone Therapy Alone for Hormone-sensitive Prostate Cancer: First Results From the STAMPEDE Randomised Controlled Trial (MRC PR08) by James, N.D, Sydes, M.R, Mason, M.D, Clarke, N.W, Dearnaley, D.P, Dwyer, J, Jovic, G, Russell, J.M, Thalmann, G, Parmar, M.K.B

Get full text

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer — A Multi-Arm Multi-Stage Randomised Controlled Trial by James, N.D, Sydes, M.R, Clarke, N.W, Mason, M.D, Dearnaley, D.P, Anderson, J, Popert, R.J, Sanders, K, Morgan, R.C, Stansfeld, J, Dwyer, J, Masters, J, Parmar, M.K.B

Get full text